Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021Sara E. Oliver, Matthew F. Daley, Monica Godfrey et al.|MMWR Morbidity and Mortality Weekly Report|2022Cited by 102
The Advisory Committee on Immunization Practices’ Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022Megan Wallace, Sara E. Oliver, Danielle Moulia et al.|MMWR Morbidity and Mortality Weekly Report|2011Cited by 43